APA (7th ed.) Citation

JJ, C., EC, K., M, N., HA, Y., CA, D., JM, M., . . . J, H. (2023). Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States. EJHaem, 4(1), 301. https://doi.org/10.1002/jha2.619

Chicago Style (17th ed.) Citation

JJ, Castillo, et al. "Zanubrutinib in Patients with Treatment-naïve or Relapsed/refractory Waldenström Macroglobulinemia: An Expanded-access Study of 50 Patients in the United States." EJHaem 4, no. 1 (2023): 301. https://doi.org/10.1002/jha2.619.

MLA (9th ed.) Citation

JJ, Castillo, et al. "Zanubrutinib in Patients with Treatment-naïve or Relapsed/refractory Waldenström Macroglobulinemia: An Expanded-access Study of 50 Patients in the United States." EJHaem, vol. 4, no. 1, 2023, p. 301, https://doi.org/10.1002/jha2.619.